Molecular mechanisms of cancer
- PMID: 1815390
- PMCID: PMC1003063
Molecular mechanisms of cancer
Abstract
Cancer is caused by specific DNA damage. Several common mechanisms that cause DNA damage result in specific malignant disorders: First, proto-oncogenes can be activated by translocations. For example, translocation of the c-myc proto-oncogene from chromosome 8 to one of the immunoglobulin loci on chromosomes 2, 14, or 22 results in Burkitt's lymphomas. Translocation of the c-abl proto-oncogene from chromosome 9 to the BCR gene located on chromosome 22 produces a hybrid BCR/ABL protein resulting in chronic myelogenous leukemia. Second, proto-oncogenes can be activated by point mutations. For example, point mutations of genes coding for guanosine triphosphate-binding proteins, such as H-, K-, or N-ras or G proteins, can be oncogenic as noted in a large variety of malignant neoplasms. Proteins from these mutated genes are constitutively active rather than being faithful second messengers of periodic extracellular signals. Third, mutations that inactivate a gene can result in tumors if the product of the gene normally constrains cellular proliferation. Functional loss of these "tumor suppressor genes" is found in many tumors such as colon and lung cancers. The diagnosis, classification, and treatment of cancers will be greatly enhanced by understanding their abnormalities at the molecular level.
Comment in
-
Molecular genetics in the cancer clinic.West J Med. 1991 Nov;155(5):544-6. West J Med. 1991. PMID: 1815412 Free PMC article. No abstract available.
Similar articles
-
The involvement of oncogenes and suppressor genes in human neoplasia.Adv Pediatr. 1987;34:1-44. Adv Pediatr. 1987. PMID: 3318293 Review.
-
Chromosomal approaches to the molecular basis of neoplasia.Symp Fundam Cancer Res. 1986;39:17-29. Symp Fundam Cancer Res. 1986. PMID: 3321306 Review.
-
Oncogenes and clinical oncology.Curr Opin Oncol. 1991 Feb;3(1):65-9. doi: 10.1097/00001622-199102000-00010. Curr Opin Oncol. 1991. PMID: 1646034 Review.
-
Chromosomal translocations in leukaemia.Semin Cancer Biol. 1993 Dec;4(6):333-40. Semin Cancer Biol. 1993. PMID: 8142618 Review.
-
[Chromosome abnormalities in human cancer].Salud Publica Mex. 1995 Mar-Apr;37(2):162-70. Salud Publica Mex. 1995. PMID: 7618117 Review. Spanish.
Cited by
-
Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy.Oncotarget. 2015 Oct 13;6(31):30787-802. doi: 10.18632/oncotarget.5021. Oncotarget. 2015. PMID: 26418750 Free PMC article.
-
Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development.Exp Mol Med. 2020 May;52(5):750-761. doi: 10.1038/s12276-020-0435-8. Epub 2020 May 21. Exp Mol Med. 2020. PMID: 32439954 Free PMC article. Review.
-
The Therapeutic Application of Hydrogen in Cancer: The Potential and Challenges.Curr Pharm Des. 2024;30(17):1295-1306. doi: 10.2174/0113816128296710240404040232. Curr Pharm Des. 2024. PMID: 38638053 Review.
-
Role of MicroRNA-7 (MiR-7) in Cancer Physiopathology.Int J Mol Sci. 2022 Aug 13;23(16):9091. doi: 10.3390/ijms23169091. Int J Mol Sci. 2022. PMID: 36012357 Free PMC article. Review.
-
Targeting MDM2-p53 Axis through Drug Repurposing for Cancer Therapy: A Multidisciplinary Approach.ACS Omega. 2023 Sep 15;8(38):34583-34596. doi: 10.1021/acsomega.3c03471. eCollection 2023 Sep 26. ACS Omega. 2023. PMID: 37779953 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous